(Q36416535)

14 August 2017

title

Osteopenia and osteoporosis in patients with HIV: a review of current concepts (English)

1 reference

14 August 2017

0 references

Todd T Brown

1

1 reference

14 August 2017

Grace A McComsey

series ordinal

2

1 reference

14 August 2017

publication date

1 March 2006

1 reference

Current infectious disease reports

14 August 2017

published in

1 reference

14 August 2017

volume

8

1 reference

14 August 2017

issue

2

1 reference

14 August 2017

page(s)

162-170

1 reference

Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

14 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11908-006-0012-X

Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11908-006-0012-X

Severe osteoporosis in men.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11908-006-0012-X

Bone mineral and soft-tissue changes in AIDS-associated lipoatrophy

21 January 2018

1 reference

12 December 2020

Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus-infected patients switched from stavudine to abacavir or zidovudine: the results of the TARHEEL study

1 reference

12 December 2020

Tenofovir treatment at 30 mg/kg/day can inhibit cortical bone mineralization in growing rhesus monkeys (Macaca mulatta).

1 reference

12 December 2020

Severe deficiency of 1,25-dihydroxyvitamin D3 in human immunodeficiency virus infection: association with immunological hyperactivity and only minor changes in calcium homeostasis

1 reference

12 December 2020

Effects of pH on bone calcium and proton fluxes in vitro

1 reference

12 December 2020

Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy.

1 reference

12 December 2020

Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy

1 reference

12 December 2020

Alendronate, vitamin D, and calcium for the treatment of osteopenia/osteoporosis associated with HIV infection

1 reference

12 December 2020

Physical activity and osteoporotic fracture risk in older women. Study of Osteoporotic Fractures Research Group

1 reference

12 December 2020

Daily and cyclic parathyroid hormone in women receiving alendronate

1 reference

12 December 2020

Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis

1 reference

12 December 2020

BMD Is Reduced in HIV-Infected Men Irrespective of Treatment

1 reference

12 December 2020

Bone mineral density in patients with human immunodeficiency virus infection

1 reference

12 December 2020

AZT enhances osteoclastogenesis and bone loss

1 reference

12 December 2020

Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women

1 reference

12 December 2020

HIV envelope gp120-mediated regulation of osteoclastogenesis via receptor activator of nuclear factor kappa B ligand (RANKL) secretion and its modulation by certain HIV protease inhibitors through interferon-gamma/RANKL cross-talk

1 reference

12 December 2020

Long-term safety of bisphosphonates

1 reference

12 December 2020

Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy

1 reference

12 December 2020

Accuracy of height loss during prospective monitoring for detection of incident vertebral fractures.

1 reference

12 December 2020

Associations between baseline risk factors and vertebral fracture risk in the Multiple Outcomes of Raloxifene Evaluation (MORE) Study

1 reference

12 December 2020

Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group

1 reference

12 December 2020

Effects of growth hormone-releasing hormone on bone turnover in human immunodeficiency virus-infected men with fat accumulation

1 reference

12 December 2020

Association between osteopenia/osteoporosis and the serum RANKL in HIV-infected patients

1 reference

12 December 2020

Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir

1 reference

12 December 2020

Long-term variability of markers of bone turnover in postmenopausal women and implications for their clinical use: the OFELY study.

1 reference

12 December 2020

Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection

1 reference

12 December 2020

Reduced bone density in androgen-deficient women with acquired immune deficiency syndrome wasting

1 reference

12 December 2020

Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia

1 reference

12 December 2020

[Pathologic fracture of the sacrum in an HIV patient treated with highly active antiretroviral therapy]

1 reference

12 December 2020

Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy

1 reference

12 December 2020

Iatrogenic Cushing's syndrome with osteoporosis and secondary adrenal failure in human immunodeficiency virus-infected patients receiving inhaled corticosteroids and ritonavir-boosted protease inhibitors: six cases

1 reference

12 December 2020

Pathological fractures in AIDS patients with osteopenia and osteoporosis induced by antiretroviral therapy

1 reference

12 December 2020

The Effects of Parathyroid Hormone, Alendronate, or Both in Men with Osteoporosis

1 reference

12 December 2020

Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy

1 reference

12 December 2020

Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patients

1 reference

12 December 2020

Bone mineral density abnormalities in patients with HIV infection

1 reference

12 December 2020

HIV-1 Vpr enhances production of receptor of activated NF-kappaB ligand (RANKL) via potentiation of glucocorticoid receptor activity

1 reference

12 December 2020

Fanconi's syndrome in HIV+ adults: report of three cases and literature review

1 reference

12 December 2020

Decreased bone formative and enhanced resorptive markers in human immunodeficiency virus infection: indication of normalization of the bone-remodeling process during highly active antiretroviral therapy

1 reference

12 December 2020

A case of march fracture in a patient with osteoporosis on long-term HAART

1 reference

12 December 2020

Serum hormones in men with human immunodeficiency virus-associated wasting

1 reference

12 December 2020

Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study

1 reference

12 December 2020

Severely suppressed bone turnover: a potential complication of alendronate therapy

1 reference

12 December 2020

The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signaling

1 reference

12 December 2020

Equivalent osteopenia in HIV-infected individuals studied before and during the era of highly active antiretroviral therapy

1 reference

12 December 2020

Osteoprotegerin and bone turnover markers in heavily pretreated HIV-infected patients.

1 reference

12 December 2020

Ten years' experience with alendronate for osteoporosis in postmenopausal women

1 reference

12 December 2020

Fragility Fractures in HIV-Infected Patients: Need for Better Understanding of Diagnosis and Management

1 reference

12 December 2020

Monitoring alendronate therapy for osteoporosis

1 reference

12 December 2020

Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study

1 reference

12 December 2020

Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals.

1 reference

12 December 2020

Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial

1 reference

12 December 2020

Reduced bone density in HIV-infected women

1 reference

12 December 2020

Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy

1 reference

12 December 2020

Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension

1 reference

12 December 2020

Bone mass and mineral metabolism in HIV+ postmenopausal women

1 reference

12 December 2020

Increased abdominal visceral fat is associated with reduced bone density in HIV-infected men with lipodystrophy

1 reference

12 December 2020

IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology

1 reference

12 December 2020

10.1007/S11908-006-0012-X

Identifiers

DOI

1 reference

14 August 2017

1 reference